Generative AI cuts lung cancer analysis time by 70% in new clinical study


 Artificial Intelligence is delivering real clinical benefits in Indian healthcare, moving far beyond just technical buzzwords. In a recent industry update, Ganesh Nathella of Persistent Systems shared how Generative AI is revolutionizing diagnostics. He revealed that their advanced platform has successfully reduced the time required to analyze lung cancer images by nearly 70%. This dramatic reduction allows radiologists to process scans much faster, enabling patients to begin life-saving treatments sooner. The technology works by automating the complex task of identifying tumor patterns, which traditionally consumes hours of a specialist's time. 

By embedding these AI models into frontline tools, doctors can identify disease patterns earlier and with greater accuracy. Nathella emphasized that this is about "democratizing healthcare." By running these sophisticated tools on low-resource mobile platforms, advanced cancer screening can now reach remote areas, ensuring that high-quality diagnostics are available to populations that previously lacked access to specialist care.

Read the original article at: https://www.pharmabiz.com/NewsDetails.aspx?aid=182569&sid=1


Follow us on Instagram, Twitter, and Facebook to stay up to date with what's new in healthcare all around the world.

Comments

Popular posts from this blog

AI meets Spirituality: New initiatives explore digital consciousness and technology's role in moral growth

India strengthens pandemic preparedness with a "One Health" approach and robust surveillance systems

IIT Jodhpur researchers develop a low-cost AI algorithm to detect cataracts using near-infrared cameras